0000899243-22-024054.txt : 20220624
0000899243-22-024054.hdr.sgml : 20220624
20220624171022
ACCESSION NUMBER: 0000899243-22-024054
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220606
FILED AS OF DATE: 20220624
DATE AS OF CHANGE: 20220624
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Aziz Kabeer
CENTRAL INDEX KEY: 0001914847
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41331
FILM NUMBER: 221040880
MAIL ADDRESS:
STREET 1: 376 MANHATTAN AVENUE APT. 3
CITY: BROOKLYN
STATE: NY
ZIP: 11211
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AN2 Therapeutics, Inc.
CENTRAL INDEX KEY: 0001880438
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 820606654
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1800 EL CAMINO REAL, SUITE D
CITY: MENLO PARK
STATE: CA
ZIP: 94027
BUSINESS PHONE: (650) 331-9090
MAIL ADDRESS:
STREET 1: 1800 EL CAMINO REAL, SUITE D
CITY: MENLO PARK
STATE: CA
ZIP: 94027
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-06-06
0
0001880438
AN2 Therapeutics, Inc.
ANTX
0001914847
Aziz Kabeer
C/O AN2 THERAPEUTICS, INC.
1800 EL CAMINO REAL, SUITE D
MENLO PARK
CA
94027
1
0
1
0
Common Stock
2022-06-06
4
J
0
26511
15.00
D
2184224
I
By Adjuvant Global Health Technology Fund, L.P.
Common Stock
2022-06-06
4
J
0
26511
15.00
A
413156
I
By Adjuvant Global Health Technology Fund DE, L.P.
On June 6, 2022, Adjuvant Global Health Technology Fund, L.P. ("AGHT Fund") transferred to Adjuvant Global Health Technology Fund DE, L.P. ("AGHT Fund DE") 26,511 shares of the Issuer's common stock, with a value of $15.00 per share, which is the per share cost of the shares acquired by AGHT Fund.
Shares held directly by AGHT Fund. The sole general partner of AGHT Fund is Adjuvant Capital GP, L.P. ("AC GP") and the sole general partner of AC GP is Adjuvant Capital Management, L.L.C. ("AC MGMT"). The Reporting Person is a member of the Issuer's board of directors and is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.
Shares held directly by AGHT Fund DE. The sole general partner of AGHT Fund DE is AC GP and the sole general partner of AC GP is AC MGMT. The Reporting Person is a member of the Issuer's board of directors and is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.
/s/ Kabeer Aziz
2022-06-24